Study provides new look at why rare cancer often evades treatments
Por um escritor misterioso
Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Count Me In launches a rare cancer research project to engage leiomyosarcoma patients and families
Study provides new look at why rare cancer often evades treatments
A research team searches for every gene that helps tumors evade immunotherapy
Cancers, Free Full-Text
CAR T-cell therapy turns blood into a cancer-fighting weapon
New look at why rare cancer often evades treatments - ecancer
The Possibilities and Risks of Genetically Altering Immune Cells to Fight Cancer, Science
Investigating the Abscopal Effect as a Treatment for Cancer - NCI
Microbiome in cancer: Role in carcinogenesis and impact in therapeutic strategies - ScienceDirect
Discovering targets and biomarkers for immunotherapies - Genevia Technologies
Cancers, Free Full-Text
Resistant cancer cells can be targeted for elimination — Harvard Gazette
Liquid Biopsy' Blood Test for Cancer Cells Boosted
The future of early cancer detection
de
por adulto (o preço varia de acordo com o tamanho do grupo)